Xigen logo

Xigen

Brand · Biotechnology Research

Company overview

Xigen is a clinical phase biopharmaceutical company developing anti-inflammatory peptide based therapeutics expected to capture market share from both anti-TNF biologics and steroids.The company is uniquely positioned to exploit know-how on the targeted cellular delivery of optimised peptide-based products or small molecules employing proprietary carrier motifs
Founded in 2002
CHE
6 employees
www.xigenpharma.com

Salaries

Typical salary range

£35,000 – £40,000

/ yr

Help build salary transparency at Xigen

Share your compensation anonymously to see full data.

Contribute

People

Headcount trend

Company growth over the last 12 months

Headcount 0% year over year

Funding

Total funding

$41M

Last raise

$20M

Series B, 17 years ago

Funding history

Nov 2009

Series B Xigen · $20M

Sep 2005

Series A Xigen · $21M

Audience

Monthly website visitors
0
Month over month0%
Quarter over quarter0%
Top sourceSearch (0%)
Ad budget per month$0.0
Average search rank61.9

LinkedIn followers

Follower count and growth

Total followers

282

12-mo growth

+2.5%

Monthly growth

0%

News

Links

www.xigenpharma.comLinkedInCrunchbase